ÂÜÀòÂÒÂ×

Shelly Maximov is an experienced professional in preclinical development and regulation, currently serving as the Director of Preclinical Development & Regulation at Omnix Medical since October 2020. Shelly has also held positions as an R&D Scientist, In-Vivo Project Manager, and Research Associate at Omnix Medical. Prior to this, Shelly worked as an Assistant Research Analyst at the Bioinformatics Unit of the I-CORE Computation Center at The Hebrew University and Hadassah from January 2020 to October 2020. Academically, Shelly is pursuing a Master of Business Administration - MBA in Business/Data Science at The Hebrew University of Jerusalem, expected to be completed in October 2024, and holds a B.Sc/Eng. in Pharmaceutical Engineering from Jerusalem College of Engineering, completed in October 2021.